William Pridgen - Jun 15, 2023 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
Director
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
VIRI
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 01:53 PM
Previous filing
Jun 30, 2022
Next filing
Aug 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +5.25K $0.00 5.25K Jun 15, 2023 Common Stock 5.25K $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on June 14, 2024, one year following the grant date.